Rex L Jamison
Affiliation: Stanford University
- Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trialRex L Jamison
Veterans Affairs Palo Alto Health Care Systems and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94304, USA
JAMA 298:1163-70. 2007..Folic acid and B vitamins decrease homocysteine levels in this population but whether they lower mortality is unknown...
- Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective studyRex L Jamison
Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
Am J Kidney Dis 53:779-89. 2009..Abnormalities in the gene regulating methylenetetrahydrofolate reductase (MTHFR) are associated with increased homocysteine levels and increased mortality in normal and chronic kidney disease (CKD) populations...
- Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) studyRex L Jamison
Division of Nephrology, Stanford University School of Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
Clin Trials 1:451-60. 2004..Data will be stored and analyzed at a coordinating center. The study design has the power to detect a reduction in all cause mortality rate of 17%. Issues related to the unique features of the design of this study are discussed...